
About Vyro Bio
Vyro Bio is a Healthcare company based in Sao Paulo (Brazil) founded in 2021 by Hugo Cabrera. Oncolytic virus drugs are developed for central nervous system tumors. Vyro Bio offers products and services including Zika Virus Treatment and Viral-based Therapeutics. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.
Company details
Founded in 2021 in Sao Paulo, Brazil, therapeutics based on Zika virus are developed by Vyro Bio to target cancer cells and malignant tumors in the adult and pediatric central nervous system. Operations are conducted within the biotechnology sector, with emphasis on oncolytic viruses for oncology applications. The companys activities center on advancing treatments for CNS-related cancers through innovative viral mechanisms.
- Headquarters Sao Paulo, Brazil
- Founders Hugo Cabrera
- SectorsHealthcare
- Website vyrobio.com
- Social LinkedIn Instagram YouTube
Products & Services of Vyro Bio
Vyro Bio offers a comprehensive portfolio of products and services, including Zika Virus Treatment and Viral-based Therapeutics.
Develops treatments using modified viruses to address health issues like Zika.
Creates engineered virus treatments for revolutionary medical applications.
Apps and channels of Vyro Bio
its YouTube channel VYRO has 10 subscribers and 1 videos.
Videos from Vyro Bio
The most watched videos on Vyro Bio's YouTube channel, VYRO (10 subscribers). Click a video to play it here.
More on VYRO.
People of Vyro Bio
9 people are tracked at Vyro Bio (1 in leadership, 7 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Hugo Cabrera | Co-Founder | Leadership |
Marcia De Souza Lima | Scientific Advisor | Board & advisors |
Caroline Chaul | Medical Advisor | Board & advisors |
Ernesto Goulart | Co-Founder | Board & advisors |
Mayana Zatz | Co-founder & Scientific Advisor | Board & advisors |
Keith Okamoto | Cofounder & Board Member | Board & advisors |
Harry Bulstrode | Scientific Advisor | Board & advisors |
Jorge Kalil | Board Member | Board & advisors |
Flávia Santoro | Marketing Assistant | Team |
Complete people profiles for Vyro Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Vyro Bio
The website of Vyro Bio (vyrobio.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▲ 58.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vyro Bio
Vyro Bio was founded in 2021.
Vyro Bio is headquartered in Sao Paulo, Brazil.
Founded in 2021 in Sao Paulo, Brazil, therapeutics based on Zika virus are developed by Vyro Bio to target cancer cells and malignant tumors in the adult and pediatric central nervous system. Operations are conducted within the biotechnology sector, with emphasis on oncolytic viruses for oncology applications. The companys activities center on advancing treatments for CNS-related cancers through innovative viral mechanisms.
Vyro Bio offers Zika Virus Treatment and Viral-based Therapeutics.